Literature DB >> 2885668

RU 486 administration in a child with Cushing's syndrome.

B Beaufrère, L de Parscau, P Chatelain, Y Morel, M Aguercif, R François.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2885668     DOI： 10.1016/s0140-6736(87)90796-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.

Authors:  Alicia Santos; Eugenia Resmini; Juan Carlos Pascual; Iris Crespo; Susan M Webb
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

3.  Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.

Authors:  Yongli Ji; Cathryn Rankin; Steven Grunberg; Andy E Sherrod; Jamshid Ahmadi; Jeannette J Townsend; Lynn G Feun; Ruth K Fredericks; Christy A Russell; Fairooz F Kabbinavar; Keith J Stelzer; Anne Schott; Claire Verschraegen
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

Review 4.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

Review 5.  Mifepristone: is there a place in the treatment of Cushing's disease?

Authors:  John D Carmichael; Maria Fleseriu
Journal:  Endocrine       Date:  2012-11-29       Impact factor: 3.633

6.  Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.

Authors:  C Yan; H Yang; Y Wang; Y Dong; F Yu; Y Wu; W Wang; U Adaku; K Lutfy; T C Friedman; S Tian; Y Liu
Journal:  Int J Obes (Lond)       Date:  2016-04-22       Impact factor: 5.095

7.  A case of hypocortisolemic clinical Cushing's syndrome.

Authors:  Kamal A S Al-Shoumer; Mohamad F Hafez; Suhail A R Doi
Journal:  Ann Saudi Med       Date:  2008 Mar-Apr       Impact factor: 1.526

8.  Mitigation of metabolic dyshomeostasis by glucocorticoid-receptor antagonism: Insights from animal and human studies.

Authors:  Aishwariya Madhavan; Kusuma Murali; Vaishnavi Raghavendra; Apurva Kumar Ramesh Joshi
Journal:  EXCLI J       Date:  2020-09-09       Impact factor: 4.068
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.